Bullionaire

[TimAlerts] I'm in $NBY because they got a new global distributor for their eye care drug. Also, SPHS got two analyst upgrades according to Zacks report and a presented at a health conference. But $ONCY and $RXII look good today. How much do orphan drug designations affect the stocks? Do they always go up on this news?

Page
of 15